keyword
https://read.qxmd.com/read/36773669/macrophage-cell-membrane-infused-biomimetic-liposomes-for-glioblastoma-targeted-therapy
#41
JOURNAL ARTICLE
D Mendanha, J Vieira de Castro, M R Casanova, S Gimondi, H Ferreira, N M Neves
Glioblastoma (GBM) is a highly aggressive malignant brain tumor currently without an effective treatment. Inspired by the recent advances in cell membrane biomimetic nanocarriers and by the key role of macrophages in GBM pathology, we developed macrophage membrane liposomes (MML) for GBM targeting. For the first time, it was assessed the role of macrophage polarization states in the effectiveness of these drug delivery systems. Interestingly, we observed that MML derived from M2 macrophages (M2 MML) presents higher uptake and increased delivery of the anticarcinogenic drug doxorubicin compared to M1 macrophage-derived nanocarriers (M1 MML) and control liposomes (CL)...
February 10, 2023: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/36765504/-effect-of-hypoxia-supported-umbilical-cord-mesenchymal-stem-cells-on-the-expansion-of-cord-blood-mononuclear-cells-in-vitro
#42
JOURNAL ARTICLE
Jing Yu, Li Xu
OBJECTIVE: To explore the effect of hypoxia-supported umbilical cord mesenchymal stem cell (UC-MSC) on the expansion of cord blood mononuclear cell (MNC) in vitro. METHODS: The isolated cord blood mononuclear cells were inoculated on the preestablished umbilical cord mesenchymal stem cell layer and cultured under hypoxic conditions (3% O2 ) and the experimental groups were normoxia (MNCs were cultured under normoxic conditions), hypoxia (MNCs were cultured under hypoxic conditions), UC-MSC (MNCs were cultured with UC-MSC under normoxic conditions), and UC-MSC+hypoxia (MNCs were cultured with UC-MSC under hypoxic conditions)...
February 2023: Zhongguo Shi Yan Xue Ye Xue za Zhi
https://read.qxmd.com/read/36699426/safety-and-efficacy-of-bendamustine-and-rituximab-br-regimen-in-indian-chronic-lymphocytic-leukaemia-patients
#43
JOURNAL ARTICLE
Ajay Gogia, Ritu Gupta, Atul Sharma, Lalit Kumar, Lata Rani, Saumyaranjan Mallick
We investigated the safety and efficacy of bendamustine-rituximab (BR) in previously untreated symptomatic and advanced CLL patients, as there is no data available on BR from the Indian subcontinent.This retrospective study included 120 consecutive treatment naïve patients with CLL without del (17p), who were registered at the Department of Medical Oncology, AIIMS between January 2010 and July 2018. Bendamustine was given at a dose of 90 mg/m2 on days 1 and 2, combined with rituximab 375 mg/m2 rituximab on day 1, every 28 days for up to 6 courses...
January 2023: Indian Journal of Hematology & Blood Transfusion
https://read.qxmd.com/read/36567491/activation-induced-marker-aim-assays-for-identification-of-t-cruzi-specific-cd4-or-cd8-t-cells-in-chronic-chagas-disease-patients
#44
JOURNAL ARTICLE
Fátima Ferragut, Karen M Cruz, Juan P Gallardo, Marisa Fernández, Yolanda Hernández, Karina A Gómez
Antigen-specific T cells are central to the adaptive immune response against T. cruzi infection and underpin the efficacy of on-going vaccine strategies. In this context, the present study focuses on T cell assays that define the parasite-specificity on the basis of upregulation of TCR stimulation-induced surface markers (AIM). For this purpose, we tested different dual marker combinations (OX40, CD25, CD40L, CD137, CD69, PD-L1, CD11a, CD49d, HLA-DR, CD38) to reliably identify activated CD4+ and CD8+ T cell populations from PBMCs of chronic Chagas disease patients (CCD) after 12 or 24 h of stimulation with T...
December 25, 2022: Immunology
https://read.qxmd.com/read/36543880/single-cell-analysis-reveals-the-chemotherapy-induced-cellular-reprogramming-and-novel-therapeutic-targets-in-relapsed-refractory-acute-myeloid-leukemia
#45
JOURNAL ARTICLE
Kening Li, Yuxin Du, Yun Cai, Wenjie Liu, Yan Lv, Bin Huang, Lishen Zhang, Zhi Wang, Ping Liu, Qian Sun, Ning Li, Mengyan Zhu, Bakwatanisa Bosco, Liangyu Li, Wei Wu, Lingxiang Wu, Jianyong Li, Qianghu Wang, Ming Hong, Sixuan Qian
Chemoresistance and relapse are the leading cause of AML-related deaths. Utilizing single-cell RNA sequencing (scRNA-seq), we dissected the cellular states of bone marrow samples from primary refractory or short-term relapsed AML patients and defined the transcriptional intratumoral heterogeneity. We found that compared to proliferating stem/progenitor-like cells (PSPs), a subpopulation of quiescent stem-like cells (QSCs) were involved in the chemoresistance and poor outcomes of AML. By performing longitudinal scRNA-seq analyses, we demonstrated that PSPs were reprogrammed to obtain a QSC-like expression pattern during chemotherapy in refractory AML patients, characterized by the upregulation of CD52 and LGALS1 expression...
February 2023: Leukemia
https://read.qxmd.com/read/36531546/flow-cytometric-expression-of-cd49d-in-newly-diagnosed-chronic-lymphocytic-leukemia-and-its-correlation-with-established-prognostic-markers
#46
JOURNAL ARTICLE
Arathi Kunnumbrath, Neha Singh, Arvind Kumar Gupta, Nilotpal Chowdhury, Uttam Kumar Nath, Harish Chandra
Introduction  Chronic lymphocytic leukemia (CLL) is the commonest hematological malignancy in the West but is relatively uncommon in India. The prognosis of CLL is determined by well-established prognostic markers. CD49d has been emerging as a promising prognostic marker in CLL. CD49d expression in CLL has been found to have an aggressive clinical course, shorter time to first treatment, and poorer prognosis. The aim of this study was to analyze the flow cytometric expression of CD49d in newly diagnosed CLL and to correlate its expression with clinico-hematological parameters...
December 2022: Journal of Laboratory Physicians
https://read.qxmd.com/read/36499497/cd200-as-a-potential-new-player-in-inflammation-during-rotator-cuff-tendon-injury-repair-an-in-vitro-model
#47
JOURNAL ARTICLE
Raffaella Giancola, Francesco Oliva, Marialucia Gallorini, Noemi Michetti, Clarissa Gissi, Fadl Moussa, Cristina Antonetti Lamorgese Passeri, Alessia Colosimo, Anna Concetta Berardi
Rotator cuff tendon (RCT) disease results from multifactorial mechanisms, in which inflammation plays a key role. Pro-inflammatory cytokines and tendon stem cell/progenitor cells (TSPCs) have been shown to participate in the inflammatory response. However, the underlying molecular mechanism is still not clear. In this study, flow cytometry analyses of different subpopulations of RCT-derived TSPCs demonstrate that after three days of administration, TNFα alone or in combination with IFNγ significantly decreases the percentage of CD146+CD49d+ and CD146+CD49f+ but not CD146+CD109+ TSPCs populations...
December 2, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36437190/allogeneic-cord-blood-regulatory-t-cells-can-resolve-lung-inflammation
#48
JOURNAL ARTICLE
Mi-Ae Lyu, Meixian Huang, Ke Zeng, Li Li, Joseph D Khoury, Mitsutaka Nishimoto, Hongbing Ma, Tara Sadeghi, Siddhartha Mukherjee, Arthur S Slutsky, Christopher R Flowers, Simrit Parmar
BACKGROUND AIMS: CD4+ CD25+ CD127lo regulatory T cells (Tregs) are responsible for maintaining immune homeostasis. Tregs can be rendered defective and deficient as a result of the immune imbalance seen in lung injury, and such dysfunction can play a major role in continued tissue inflammation. The authors hypothesized that adoptive therapy with healthy allogeneic umbilical cord blood (UCB)-derived Tregs may be able to resolve inflammation. RESULTS: Ex vivo-expanded UCB Tregs exhibited a unique phenotype with co-expression of CD45RA+ CD45RO+ >80% and lung homing markers, including CD49d...
November 24, 2022: Cytotherapy
https://read.qxmd.com/read/36413502/elevation-of-cell-associated-hiv-1-transcripts-in-csf-cd4-t-cells-despite-effective-antiretroviral-therapy-is-linked-to-brain-injury
#49
JOURNAL ARTICLE
Kazuo Suzuki, John Zaunders, Thomas M Gates, Angelique Levert, Shannen Butterly, Zhixin Liu, Takaomi Ishida, Sarah Palmer, Caroline D Rae, Lauriane Jugé, Lucette A Cysique, Bruce J Brew
Antiretroviral therapy (ART) can attain prolonged undetectable HIV-1 in plasma and cerebrospinal fluid (CSF), but brain injury remains prevalent in people living with HIV-1 infection (PLHIV). We investigated cell-associated (CA)-HIV-1 RNA transcripts in cells in CSF and blood, using the highly sensitive Double-R assay, together with proton Magnetic Resonance Spectroscopy (1 H MRS) of major brain metabolites, in sixteen PLHIV. 14/16 CSF cell samples had quantifiable CA-HIV-1 RNA, at levels significantly higher than in their PBMCs (median 9,266 vs 185 copies /106 CD4+ T-cells; p<0...
November 29, 2022: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/36330506/exploring-the-immunomodulatory-role-of-virtual-memory-cd8-t-cells-role-of-ifn-gamma-in-tumor-growth-control
#50
JOURNAL ARTICLE
Constanza Savid-Frontera, Maria Estefania Viano, Natalia S Baez, Nicolas L Lidon, Quentin Fontaine, Howard A Young, Lene Vimeux, Emmanuel Donnadieu, Maria Cecilia Rodriguez-Galan
Virtual memory CD8+ T cells (TVM ) have been described as cells with a memory-like phenotype but without previous antigen (Ag) exposure. TVM cells have the ability to respond better to innate stimuli rather than by TCR engagement, producing large amounts of interferon gamma (IFNγ) after stimulation with interleukin (IL)-12 plus IL-18. As a result of the phenotypic similarity, TVM cells have been erroneously included in the central memory T cell subset for many years. However, they can now be discriminated via the CD49d receptor, which is up-regulated only on conventional memory T cells (TMEM ) and effector T cells (TEFF ) after specific cognate Ag recognition by a TCR...
2022: Frontiers in Immunology
https://read.qxmd.com/read/36308917/g%C3%A3-ttingen-pigs-as-a-potential-model-for-natalizumab-pharmacokinetics-pharmacodynamics-and-immunogenicity-evaluation
#51
JOURNAL ARTICLE
Tomasz Grabowski, Rafał Derlacz, Artur Burmańczuk
Natalizumab is a recombinant, humanized form of a monoclonal antibody that binds to CD49d. The presented study was conducted to explore the suitability of Göttingen pigs as a pharmacokinetic/pharmacodynamic model in the preclinical phase of biosimilar natalizumab development. The minipigs were treated with 1.286 or 3.0 mg of natalizumab (Tysabri®) per kg of body weight by a single 1-hour intravenous infusion. Six days before (baseline) and 30 days after administration of the single dose of natalizumab, blood samples were taken for analysis...
October 26, 2022: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/36032101/an-enhanced-level-of-vcam-in-transplant-preservation-fluid-is-an-independent-predictor-of-early-kidney-allograft-dysfunction
#52
JOURNAL ARTICLE
Michael Baboudjian, Bastien Gondran-Tellier, Romain Boissier, Patricia Ancel, Juline Marjollet, Luc Lyonnet, Pauline François, Florence Sabatier, Eric Lechevallier, Anne Dutour, Pascale Paul
Background: We aimed to evaluate whether donor-related inflammatory markers found in kidney transplant preservation fluid can associate with early development of kidney allograft dysfunction. Methods: Our prospective study enrolled 74 consecutive donated organs who underwent kidney transplantation in our center between September 2020 and June 2021. Kidneys from 27 standard criteria donors were allocated to static cold storage and kidneys from 47 extended criteria donors to hypothermic machine perfusion...
2022: Frontiers in Immunology
https://read.qxmd.com/read/36032099/the-potential-role-of-exosomal-mirnas-and-membrane-proteins-in-acute-hiv-infected-people
#53
JOURNAL ARTICLE
Xin Li, Wenjing Wang, Jing Chen, Bangxiang Xie, Shumin Luo, Dexi Chen, Chao Cai, Chuanyun Li, Weihua Li
Exosomes play an important role during human immunodeficiency virus (HIV) acute infection. Yet, information regarding its cargo and its association with HIV rapid progressors (RPs) and typical progressors (TPs) remain largely unknown. In this study, exosomal miRNAs sequencing and mass cytometry were used to identify differential exosomal miRNAs and membrane proteins that participate in the pathogenesis of TPs and RPs. We discovered that miR-144-5p, miR-1180-3p, miR-451a, miR-362-5p, and miR-625-5p are associated with the TPs and miR-362-5p with the RPs...
2022: Frontiers in Immunology
https://read.qxmd.com/read/35968589/-study-of-cytogenetics-and-molecular-biology-in-typical-and-atypical-immunophenotypic-chronic-lymphocytic-leukemia
#54
JOURNAL ARTICLE
H M Jin, C Qiao, S S Zhao, H R Qiu, X Chen, H Yang, L Y Zhu, J Y Li, Y J Wu
Objective: To analyze the differences in immunophenotype, cytogenetics, and molecular biology between typical and atypical immunophenotype chronic lymphocytic leukemia (CLL) , and explore the correlation of cytogenetic anomalies with gene mutations. Methods: This study included 488 patients diagnosed in the First Affiliated Hospital of Nanjing Medical University between November 2014 and May 2021. Of these, 382 patients scored 4-5 points, which was typical CLL (tCLL) , and 106 scored 3 points, which was atypical CLL (aCLL) as per the Royal Marsden Hospital Immunomarker Integral System...
June 14, 2022: Zhonghua Xue Ye Xue za Zhi, Zhonghua Xueyexue Zazhi
https://read.qxmd.com/read/35968588/-the-correlation-of-cd49d-expression-pattern-with-molecular-genetics-and-hotspot-gene-mutants-in-patients-with-chronic-lymphocytic-leukemia
#55
JOURNAL ARTICLE
J Zhu, L Liu, X Chen, F Liu, S S Zhao, H M Jin, H R Qiu, C Qiao, J Y Li, Y J Wu
Objective: To explore the correlation of CD49d expression patterns with molecular genetics and hotspot gene mutants in patients with chronic lymphocytic leukemia. Methods: The expression of CD49d was detected by flow cytometry and grouped into homogeneous, bimodal, negative and positive expression. Panel fluorescence in situ hybridization (FISH) was used for molecular genetics analysis and next-generation sequencing (NGS) was conducted for gene mutation detection. Results: There were 43 patients (23.89% ) with positive CD49d expression, 137 patients (76...
June 14, 2022: Zhonghua Xue Ye Xue za Zhi, Zhonghua Xueyexue Zazhi
https://read.qxmd.com/read/35913400/early-cd49d-downmodulation-in-chronic-lymphocytic-leukemia-patients-treated-front-line-with-ibrutinib-plus-rituximab-predicts-long-term-response
#56
JOURNAL ARTICLE
Nadia Peragine, Maria Stefania De Propris, Stefania Intoppa, Maria Laura Milani, Francesca Romana Mauro, Antonio Cuneo, Gian Matteo Rigolin, Ilaria Del Giudice, Robin Foà, Anna Guarini
No abstract text is available yet for this article.
August 1, 2022: Leukemia & Lymphoma
https://read.qxmd.com/read/35883678/integrin-signaling-shaping-btk-inhibitor-resistance
#57
REVIEW
Laura Polcik, Svenja Dannewitz Prosseda, Federico Pozzo, Antonella Zucchetto, Valter Gattei, Tanja Nicole Hartmann
Integrins are adhesion molecules that function as anchors in retaining tumor cells in supportive tissues and facilitating metastasis. Beta1 integrins are known to contribute to cell adhesion-mediated drug resistance in cancer. Very late antigen-4 (VLA-4), a CD49d/CD29 heterodimer, is a beta1 integrin implicated in therapy resistance in both solid tumors and haematological malignancies such as chronic lymphocytic leukemia (CLL). A complex inside-out signaling mechanism activates VLA-4, which might include several therapeutic targets for CLL...
July 18, 2022: Cells
https://read.qxmd.com/read/35871396/implementation-of-international-prognostic-index-with-flow-cytometry-immunophenotyping-for-better-risk-stratification-of-chronic-lymphocytic-leukemia
#58
JOURNAL ARTICLE
Valentina Giudice, Bianca Serio, Angela Bertolini, Laura Mettivier, Francesca D'Alto, Luca Pezzullo, Matteo D'Addona, Rosalba Fumo, Pio Zeppa, Marisa Gorrese, Carmine Selleri
BACKGROUND: Current chronic lymphocytic leukemia (CLL) International Prognostic Index (IPI) stratifies patients based on clinical, molecular, and biochemical features; however, B-cell markers also influence CLL outcomes. Here, prognostic roles of CD11c, CD38, and CD49d were first evaluated, and then an immunophenotypic score was combined with CLL-IPI for risk stratification of CLL patients. METHODS: A total of 171 CLL subjects were included, and surface marker expression was assessed by flow cytometry...
November 2022: European Journal of Haematology
https://read.qxmd.com/read/35776688/low-cd49d-expression-in-newly-diagnosed-chronic-lymphocytic-leukaemia-may-be-associated-with-high-risk-features-and-reduced-treatment-free-intervals
#59
JOURNAL ARTICLE
Smyth Elizabeth, Kelly Aidan, O' Brien David, Waldron Deirdre, Brophy Sarah, Atkinson Emer, Perera Kanthi, Gerard M Crotty, Walsh Aileen, Connolly Michelle, Clifford Ruth, O'Leary Hilary, Khan Ashique, Christopher L Bacon, Smyth Emily, Anthony M McElligott, Quinn Fiona, Vandenberghe Elisabeth, Waldron Carmel
This study was carried out to assess the prognostic power of low CD49d expression (≥10%) in newly diagnosed CLL patients using a previously described cohort. Eighty-five patients were included. Median age at diagnosis; 70 years (43-88); CD49d was expressed in 33/85 (38.8%); 23/33 (69.7%) at ≥30% referred to as 'HiCD49d' and 10/33 (30.3%) between 10 and 30% with a bimodal pattern on scatterplot analysis referred to as 'LoCD49d'. Eleven patients (12.9%) presented as Binet stage B, of whom 8 (72.7%) were CD49d+ (HiCD49d 7/8; LoCD49d 1/8)...
July 1, 2022: European Journal of Haematology
https://read.qxmd.com/read/35727432/glycan-epitope-and-integrin-expression-dynamics-characterize-neural-crest-epithelial-to-mesenchymal-transition-emt-in-human-pluripotent-stem-cell-differentiation
#60
JOURNAL ARTICLE
Ria Thomas, Vishal Menon, Rakesh Mani, Jan Pruszak
The neural crest gives rise to progeny as diverse as peripheral neurons, myelinating cells, cranial muscle, bone and cartilage tissues, and melanocytes. Neural crest derivation encompasses complex morphological change, including epithelial-to-mesenchymal transition (EMT) and migration to the eventual target locations throughout the body. Neural crest cultures derived from stem cells provide an attractive source for developmental studies in human model systems, of immediate biomedical relevance for neurocristopathies, neural cancer biology and regenerative medicine, if only appropriate markers for lineage and cell type definition and quality control criteria were available...
June 21, 2022: Stem cell reviews and reports
keyword
keyword
164344
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.